KIT and systemic mastocytosis: Indeed, EVs derived from the sera of SM patients or from the human HMC-1 cell line affected the activation of hepatic stellate cells (HSC) by transferring active KIT from SM-EVs into the HSC cell line, resulting in proliferation, cytokine production, and differentiation of HSC, a process associated with liver pathology.